Healthcare ed-tech startup Virohan has raised $7 million in Pre-Series B1 round led by Bloom Ventures.
The round saw participation from India Inclusion Seed Fund, Rebright Partners and Lessing Earth Limited, Harsh Vardhan as part of Let’s Venture, ALES Japan, Shantanu Jain – Managing Director, JP Morgan Chase – Singapore, Deepa Bagla Financial Consultants and others Includes $500K from Rajgarhia. This brings the total capital raised to date to $11 million.
With this fund-raising, Virohan aims to expand to over 200 new campuses across India and train over 7,000 students. The company also plans to use the new funds to develop and launch new training programs, develop new features as well as enhance the infrastructure of its omnichannel training platform and local language content. The funding will help the company expand into the Japanese markets with the support of its existing investors ALES and Rebright Partners, the company said.
Kunal Dudeja, Co-Founder and CEO, Virohan said, “This investment is a testament to the product-market fit, scalability, impact and profitability of our business model. Over the next 18 months, Virohan will be able to support its stakeholders – students, universities/colleges and medical institutions. will further deepen its ties with the U.S., train over 10,000 students, and establish an international presence to meet the $100 billion global opportunity.
Virohan is a healthcare ed-tech platform that trains students in Allied Healthcare Programs (AHP). AHPs are technicians in the healthcare industry, who comprise 60 percent of the healthcare workforce and include phlebotomists, medical lab technicians, operating theater technicians, and more.
Virohan was founded in 2018 by Kunal Dudeja, Nalin Saluja and Archit Jaiswal, who come with strong backgrounds in retail, merchandising, technology, product development and finance.